Keyphrases
Viral Entry
100%
Viral Infection
100%
SARS-CoV-2 Spike Protein
100%
Factor Xa Inhibitors
100%
Factor Xa
100%
COVID-19
66%
Spike Protein
66%
Serine Protease
66%
COVID-19 Patients
66%
Fondaparinux
66%
Rivaroxaban
66%
Virus
33%
Antiviral Activity
33%
Unknown Function
33%
Antiviral Response
33%
Angiotensin-converting Enzyme 2 (ACE2)
33%
Trypsin
33%
K18-hACE2
33%
Anticoagulants
33%
Furin
33%
D614G mutation
33%
SARS-CoV-2 Spike (S) Protein
33%
Blood Coagulation
33%
Thrombotic Complications
33%
Transmembrane Protease Serine 2 (TMPRSS2)
33%
Protein Cleavage
33%
Host Defense Mechanisms
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Blood Clotting Factor 10a
100%
Vitronectin
75%
Serine Proteinase
50%
Rivaroxaban
50%
Fondaparinux
50%
Antiviral Activity
25%
Antivirus Agent
25%
F Factor
25%
Anticoagulant Agent
25%
Furin
25%
K 18
25%